SENSITIVITY OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELS TO VARIATION IN MODEL PARAMETERS - METHYLENE-CHLORIDE

被引:65
|
作者
CLEWELL, HJ
LEE, TS
CARPENTER, RL
机构
[1] USN,MED RES INST DETACHMENT TOXICOL,2612 5TH ST,WRIGHT PATTERSON AFB,OH 45433
[2] CLEMENT ASSOCIATES,RUSHTON,LA
[3] WESTERN ILLINOIS UNIV,DEPT MATH,MACOMB,IL 61455
关键词
LIVER; LUNG; METHYLENE CHLORIDE; PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS; PARAMETER SIGNIFICANCE; SENSITIVITY ANALYSIS;
D O I
10.1111/j.1539-6924.1994.tb00268.x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The parameters in a physiologically based pharmacokinetic (PBPK) model of methylene chloride were varied systematically, and the resulting variation in a number of model outputs was determined as a function of time for mice and humans at several exposure concentrations. The importance of the various parameters in the model was highly dependent on the conditions (concentration, species) for which the simulation was performed and the model output (dose surrogate) being considered. Model structure also had a significant impact on the results. For sensitivity analysis, particular attention must be paid to conservation equations to ensure that the variational calculations do not alter mass balance, introducing extraneous effects into the model. All of the normalized sensitivity coefficients calculated in this study ranged between -1.12 and 1, and most were much less than 1 in absolute value, indicating that individual input errors are not greatly amplified in the outputs. In addition to ranking parameters in terms of their impact on model predictions, time-dependent sensitivity analysis can also be used as an aid in the design of experiments to estimate parameters by predicting the experimental conditions and sampling points which will maximize parameter identifiability.
引用
收藏
页码:521 / 531
页数:11
相关论文
共 50 条
  • [41] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF METOCLOPRAMIDE IN SPECIAL POPULATIONS.
    Silva, L.
    Diniz, A.
    Martins, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S10 - S10
  • [42] DEVELOPMENT OF A PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF CANAGLIFLOZIN IN HUMANS.
    Courtois, K.
    Rower, J. E.
    Bradshaw-Pierce, E. L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S35 - S35
  • [43] Pharmacokinetics and development of a physiologically-based pharmacokinetic model of docetaxel in mice
    Bradshaw-Pierce, Erica L.
    Merz, Andrea L.
    Zirrolli, Joseph A.
    Gustafson, Daniel L.
    CANCER RESEARCH, 2006, 66 (08)
  • [44] Physiologically-based pharmacokinetic (PBPK) model to describe the disposition of pyronaridine
    Diep, John K.
    Lingerfelt, Mary A.
    Ekins, Sean
    Rao, Gauri G.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S34 - S34
  • [45] Physiologically-based pharmacokinetic model for 2,4-dinitrophenol
    Lyndsey F. Meyer
    Pooja M. Rajadhyaksha
    Dhaval K. Shah
    Journal of Pharmacokinetics and Pharmacodynamics, 2022, 49 : 325 - 336
  • [46] A PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PB-PK) MODEL FOR DESETHYLAMIODARONE
    HOU, ZY
    BALTER, NJ
    WOOSLEY, RL
    SCHWARTZ, SL
    CIRCULATION, 1990, 82 (04) : 196 - 196
  • [47] Development and application of a physiologically-based pharmacokinetic model for ractopamine in goats
    Ai, Jing
    Gao, Yunfeng
    Yang, Fan
    Zhao, Zhen
    Dong, Jin
    Wang, Jing
    Fu, Shiyi
    Ma, Ying
    Gu, Xu
    FRONTIERS IN VETERINARY SCIENCE, 2024, 11
  • [48] Physiologically-based pharmacokinetic model for clozapine in Korean patients with schizophrenia
    Lee, Joomi
    Kim, Min-Gul
    Jeong, Hyeon-Cheol
    Shin, Kwang-Hee
    TRANSLATIONAL AND CLINICAL PHARMACOLOGY, 2021, 29 (01) : 33 - 44
  • [49] PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL FOR PANTOPRAZOLE IN CHILDREN WITH OBESITY
    Kyler, K.
    Shakhnovich, V.
    Selvarangan, R.
    Sasidharan, A.
    Chan, S.
    Artz, N.
    Williams, V.
    Friesen, C.
    Pearce, R.
    Gaedigk, A.
    Leeder, J.
    Galetin, A.
    Johnson, T.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S106 - S107
  • [50] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR THE INHIBITION OF ACETYLCHOLINESTERASE BY ORGANOPHOSPHATE ESTERS
    GEARHART, JM
    JEPSON, GW
    CLEWELL, HJ
    ANDERSEN, ME
    CONOLLY, RB
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 : 51 - 60